Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000436230

Medchemexpress LLC Thalidomide-O-amido-PEG2-C2-NH2 (TFA) | 1957235-75-4 | 576.48 | 500 MG
SDP

Catalog No. 5000436230
Encompass_Preferred

Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate. It incorporates the Thalidomide based cereblon ligand and a 2-unit PEG linker used in PROTAC technology. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • Synthesized E3 ligase ligand-linker conjugate
  • Incorporates Thalidomide based cereblon ligand
  • Uses a 2-unit PEG linker
  • Utilized in PROTAC technology
  • Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins

Catalog No. 50-004-36230 Supplier Medchemexpress LLC Supplier No. HY112617A500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate. It incorporates the Thalidomide based cereblon ligand and a 2-unit PEG linker used in PROTAC technology. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • Synthesized E3 ligase ligand-linker conjugate
  • Incorporates Thalidomide based cereblon ligand
  • Uses a 2-unit PEG linker
  • Utilized in PROTAC technology
  • Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.